CAS: 934541-31-8 - TAK-901
Formula:C28H32N4O3S
InChI:InChI=1S/C28H32N4O3S/c1-5-36(34,35)21-8-6-7-19(14-21)23-15-22(28(33)30-20-9-11-32(4)12-10-20)18(3)26-25(23)24-13-17(2)16-29-27(24)31-26/h6-8,13-16,20H,5,9-12H2,1-4H3,(H,29,31)(H,30,33)
- Synonyms:
- 5-[3-(Ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-9H-pyrido[2,3-b]indole-7-carboxamide
- 9H-Pyrido[2,3-b]indole-7-carboxamide, 5-[3-(ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-
5-[3-(Ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-9H-pyrido[2,3-b]indole-7-carboxamide
CAS:934541-31-8
Formula:
C28H32N4O3S
Purity:
99%
Molecular weight:
504.6437
Ref: IN-DA00GU6N
1mg | 117.00 € | ||
5mg | 184.00 € | ||
10mg | 458.00 € | ||
25mg | 581.00 € | ||
50mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
TAK-901
CAS:934541-31-8
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid …
Formula:
C28H32N4O3S
Purity:
97.38% - 99.1%
Color and Shape:
Solid
Molecular weight:
504.64
Ref: TM-T2709
5mg | 76.00 € | ||
25mg | 209.00 € | ||
50mg | 363.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
TAK 901
CAS:934541-31-8
Inhibitor of Aurora B kinase
Formula:
C28H32N4O3S
Purity:
Min. 95%
Molecular weight:
504.64 g/mol
Ref: 3D-FT27989
10mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025